4595 Stock Overview
Researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Mizuho Medy Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,533.00 |
| 52 Week High | JP¥1,945.00 |
| 52 Week Low | JP¥1,190.50 |
| Beta | 0.93 |
| 11 Month Change | -9.93% |
| 3 Month Change | -11.00% |
| 1 Year Change | 25.14% |
| 33 Year Change | -13.02% |
| 5 Year Change | 18.52% |
| Change since IPO | 582.85% |
Recent News & Updates
Shareholder Returns
| 4595 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -3.6% | 7.1% | 4.6% |
| 1Y | 25.1% | 15.7% | 9.6% |
Return vs Industry: 4595 exceeded the JP Medical Equipment industry which returned 15.7% over the past year.
Return vs Market: 4595 exceeded the JP Market which returned 9.6% over the past year.
Price Volatility
| 4595 volatility | |
|---|---|
| 4595 Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.0% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 4595 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4595's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 180 | Fuminari Karakawa | www.mizuho-m.co.jp |
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits.
Mizuho Medy Co.,Ltd. Fundamentals Summary
| 4595 fundamental statistics | |
|---|---|
| Market cap | JP¥28.84b |
| Earnings (TTM) | JP¥4.00b |
| Revenue (TTM) | JP¥11.34b |
7.3x
P/E Ratio2.6x
P/S RatioIs 4595 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4595 income statement (TTM) | |
|---|---|
| Revenue | JP¥11.34b |
| Cost of Revenue | JP¥3.01b |
| Gross Profit | JP¥8.33b |
| Other Expenses | JP¥4.33b |
| Earnings | JP¥4.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 209.88 |
| Gross Margin | 73.42% |
| Net Profit Margin | 35.26% |
| Debt/Equity Ratio | 0% |
How did 4595 perform over the long term?
See historical performance and comparison